Nuwellis, Inc. stockholders' special meeting held on July 24, 2026, approved the issuance of common stock in accordance with Nasdaq Listing Rule 5635(d) and a reverse stock split in a range of 1-for-5 to 1-for-70. The company is a medical technology company that provides solutions for fluid management.
